Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C Supplementation in Autologous Stem Cell Transplantation
2018-004135-77Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ascorbic acid in multiple myeloma (MM) and lymphoma (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Plasma ascorbic acid level at day 14 and Plasma ascorbic acid level at day of neutrophil repopulation. Started Nov 2018; status: completed.
02
Drugs
ascorbic acid
03
Conditions
multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on 2018-004135-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004135-77.